- increased bone mineral density / IMPC
- abnormal vertebrae morphology / IMPC
- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased body weight / IMPC
- abnormal cornea morphology / IMPC
- abnormal eye morphology / IMPC
- abnormal tail morphology / IMPC
- abnormal eye size / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating serum albumin level / IMPC
- corneal vascularization / IMPC
- decreased circulating total protein level / IMPC
- decreased total body fat amount / IMPC
- process of degenerative change / IMPC
- inflammation / IMPC
- developmental dysplasia / IMPC
C57BL/6NTac-Pex3tm1a(EUCOMM)Wtsi/WtsiOrl
Status | Available to order |
EMMA ID | EM:05793 |
Citation information | RRID:IMSR_EM:05793 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6NTac-Pex3tm1a(EUCOMM)Wtsi/WtsiOrl |
Alternative name | EPD0103_1_H06 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Pex3tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Pex3 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0103_1_H06. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | heterozygous C57BL/6NTac males |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Zellweger syndrome / Orphanet_912
- Neonatal adrenoleukodystrophy / Orphanet_44
- Infantile Refsum disease / Orphanet_772
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased body weight / IMPC
- abnormal eye morphology / IMPC
- abnormal vertebrae morphology / IMPC
- corneal vascularization / IMPC
- increased bone mineral density / IMPC
- inflammation / IMPC
- decreased circulating HDL cholesterol level / IMPC
- abnormal tail morphology / IMPC
- decreased circulating serum albumin level / IMPC
- abnormal eye size / IMPC
- abnormal cornea morphology / IMPC
- decreased circulating total protein level / IMPC
- process of degenerative change / IMPC
- developmental dysplasia / IMPC
- decreased total body fat amount / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating LDL cholesterol level / IMPC
MGI phenotypes (allele matching)
- increased bone mineral density / MGI
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- abnormal sebaceous gland morphology / MGI
- decreased body weight / MGI
- abnormal cornea morphology / MGI
- decreased caudal vertebrae number / MGI
- abnormal eye morphology / MGI
- abnormal tail morphology / MGI
- abnormal eye size / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating cholesterol level / MGI
- decreased circulating serum albumin level / MGI
- increased mean corpuscular hemoglobin / MGI
- decreased circulating total protein level / MGI
- decreased circulating aspartate transaminase level / MGI
- abnormal hair follicle bulge morphology / MGI
- decreased total body fat amount / MGI
- increased circulating fructosamine level / MGI
- decreased circulating fructosamine level / MGI
- increased sacral vertebrae number / MGI
- small sebaceous gland / MGI
MGI phenotypes (gene matching)
- increased bone mineral density / MGI
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- abnormal sebaceous gland morphology / MGI
- decreased body weight / MGI
- abnormal cornea morphology / MGI
- decreased caudal vertebrae number / MGI
- abnormal eye morphology / MGI
- abnormal tail morphology / MGI
- abnormal eye size / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating cholesterol level / MGI
- decreased circulating serum albumin level / MGI
- increased mean corpuscular hemoglobin / MGI
- decreased circulating total protein level / MGI
- decreased circulating aspartate transaminase level / MGI
- abnormal hair follicle bulge morphology / MGI
- decreased total body fat amount / MGI
- increased circulating fructosamine level / MGI
- decreased circulating fructosamine level / MGI
- increased sacral vertebrae number / MGI
- small sebaceous gland / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).